Salix Pharmaceuticals Ltd (SLXP) Tops Q4 EPS by 2c
Tweet Send to a Friend
Salix Pharmaceuticals Ltd (NASDAQ: SLXP) reported Q4 EPS of $0.81 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
